These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24954524)

  • 1. Enzymatic glycosylation of vancomycin aglycon: completion of a total synthesis of vancomycin and N- and C-terminus substituent effects of the aglycon substrate.
    Nakayama A; Okano A; Feng Y; Collins JC; Collins KC; Walsh CT; Boger DL
    Org Lett; 2014 Jul; 16(13):3572-5. PubMed ID: 24954524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-Generation Total Synthesis of Vancomycin.
    Moore MJ; Qu S; Tan C; Cai Y; Mogi Y; Jamin Keith D; Boger DL
    J Am Chem Soc; 2020 Sep; 142(37):16039-16050. PubMed ID: 32885969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of vancomycin and vancomycin aglycon analogues that bear modifications in the residue 3 asparagine.
    McAtee JJ; Castle SL; Jin Q; Boger DL
    Bioorg Med Chem Lett; 2002 May; 12(9):1319-22. PubMed ID: 11965380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-bound glycosylation for various glycosyl acceptors: bidirectional solid-phase semisynthesis of vancomycin and its derivatives.
    Doi T; Kinbara A; Inoue H; Takahashi T
    Chem Asian J; 2007 Jan; 2(1):188-98. PubMed ID: 17441153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial glycosylation of glycopeptide antibiotics.
    Baltz RH
    Chem Biol; 2002 Dec; 9(12):1268-70. PubMed ID: 12498878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of glucose analogs by GtfE and GtfD from the vancomycin biosynthetic pathway to generate variant glycopeptides.
    Losey HC; Jiang J; Biggins JB; Oberthür M; Ye XY; Dong SD; Kahne D; Thorson JS; Walsh CT
    Chem Biol; 2002 Dec; 9(12):1305-14. PubMed ID: 12498883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
    Xie J; Okano A; Pierce JG; James RC; Stamm S; Crane CM; Boger DL
    J Am Chem Soc; 2012 Jan; 134(2):1284-97. PubMed ID: 22188323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tandem action of glycosyltransferases in the maturation of vancomycin and teicoplanin aglycones: novel glycopeptides.
    Losey HC; Peczuh MW; Chen Z; Eggert US; Dong SD; Pelczer I; Kahne D; Walsh CT
    Biochemistry; 2001 Apr; 40(15):4745-55. PubMed ID: 11294642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic investigation of the synthetic utility of glycopeptide glycosyltransferases.
    Oberthür M; Leimkuhler C; Kruger RG; Lu W; Walsh CT; Kahne D
    J Am Chem Soc; 2005 Aug; 127(30):10747-52. PubMed ID: 16045364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A programmable one-pot oligosaccharide synthesis for diversifying the sugar domains of natural products: a case study of vancomycin.
    Ritter TK; Mong KK; Liu H; Nakatani T; Wong CH
    Angew Chem Int Ed Engl; 2003 Oct; 42(38):4657-60. PubMed ID: 14533156
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural product disaccharide engineering through tandem glycosyltransferase catalysis reversibility and neoglycosylation.
    Peltier-Pain P; Marchillo K; Zhou M; Andes DR; Thorson JS
    Org Lett; 2012 Oct; 14(19):5086-9. PubMed ID: 22984807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the role of the vancomycin e-ring aryl chloride: selective divergent synthesis and evaluation of alternatively substituted E-ring analogues.
    Pinchman JR; Boger DL
    J Med Chem; 2013 May; 56(10):4116-24. PubMed ID: 23617725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silver(I)-promoted conversion of thioamides to amidines: divergent synthesis of a key series of vancomycin aglycon residue 4 amidines that clarify binding behavior to model ligands.
    Okano A; James RC; Pierce JG; Xie J; Boger DL
    J Am Chem Soc; 2012 May; 134(21):8790-3. PubMed ID: 22568755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of vancomycin aglycon analogues that bear modifications in the N-terminal D-leucyl amino acid.
    Crane CM; Boger DL
    J Med Chem; 2009 Mar; 52(5):1471-6. PubMed ID: 19209892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of selected key methyl ether derivatives of vancomycin aglycon.
    Crane CM; Pierce JG; Leung SS; Tirado-Rives J; Jorgensen WL; Boger DL
    J Med Chem; 2010 Oct; 53(19):7229-35. PubMed ID: 20853900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances in the study of synthesis and activity of vancomycin derivatives].
    Chen YY; Liu G
    Yao Xue Xue Bao; 2007 May; 42(5):463-9. PubMed ID: 17703765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of the vancomycin CDE ring system.
    Boger DL; Beresis RT; Loiseleur O; Wu JH; Castle SL
    Bioorg Med Chem Lett; 1998 Apr; 8(7):721-4. PubMed ID: 9871529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin, teicoplanin, and ramoplanin: synthetic and mechanistic studies.
    Boger DL
    Med Res Rev; 2001 Sep; 21(5):356-81. PubMed ID: 11579438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a novel series of semisynthetic vancomycin derivatives effective against vancomycin-resistant bacteria.
    Nakama Y; Yoshida O; Yoda M; Araki K; Sawada Y; Nakamura J; Xu S; Miura K; Maki H; Arimoto H
    J Med Chem; 2010 Mar; 53(6):2528-33. PubMed ID: 20180534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding interactions of vancomycin tracers with a bacterial cell wall peptidoglycan analogue.
    Adamczyk M; Grote J; Moore JA; Rege SD; Yu Z
    Bioorg Med Chem Lett; 2000 Jul; 10(14):1613-5. PubMed ID: 10915064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.